Clinical Trials Directory

Trials / Completed

CompletedNCT02628158

Fundus Autofluorescence After Vitrectomy for Epiretinal Membrane

Correlation of Postoperative Vision and Fundus Autofluorescence After Vitrectomy for Epiretinal Membrane

Status
Completed
Phase
Study type
Observational
Enrollment
91 (actual)
Sponsor
Kyorin University · Academic / Other
Sex
Age
20 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Fundus autofluorescence (FAF) at the macula originates from hyperfluorescence from retinal pigment epithelium (RPE) and blockage of hyperfluorescence by macular pigment. Investigators evaluate whether presence of FAF may correlate to the postoperative visual outcome for epiretinal membrane.

Detailed description

92 eyes with epiretinal membrane were performed vitreous surgery, epiretinal membrane removal and internal limiting membrane (ILM) peeling. Presence of hyperfluorescence in FAF at the macular area and best-corrected visual acuity (BCVA) was evaluated preoperatively and at postoperative 1, 3, and 6 months with ultra-wide angle imaging.

Conditions

Interventions

TypeNameDescription
PROCEDUREVitrectomy with internal limiting membrane removalVitrectomy with removal of epiretinal membrane and internal limiting membrane

Timeline

Start date
2013-04-01
Primary completion
2015-04-01
Completion
2015-10-01
First posted
2015-12-11
Last updated
2015-12-11

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT02628158. Inclusion in this directory is not an endorsement.